Currently studied chemokines include CCL5 (which can increase the virus's survival time at the tumor site), CCL19 (controlling tumor growth, increasing DC, CD4+ T cell migration to the TME), CCL20, and CCL2120, 55, 133, 134. Here, CD4 is linked to neoplasm.